Clinical laboratory test findings for amlodipine, valsartan and hydrochlorothiazide were obtained in a controlled trial of amlodipine, valsartan and hydrochlorothiazide administered at the maximal dose of 10 mg/320 mg/25 mg compared to maximal doses of dual therapies, i.e, valsartan/hydrochlorothiazide 320 mg/25 mg, amlodipine/valsartan 10 mg
Maximum dose: Valsartan 320 mg/hydrochlorothiazide 25 mg per day. While in case of add-on/replacement therapy: Valsartan 80 to 320 mg/hydrochlorothiazide 12.5
Valsartan / hydrochlorothiazide 160 mg /12.5 mg; Valsartan / hydrochlorothiazide 160 mg / 25 mg; Valsartan / hydrochlorothiazide 320 mg / 12.5
320 mg valsartan and 12.5 mg hydrochlorothiazide, or 320 mg valsartan and 25 mg hydrochlorothiazide. Certain dosage strengths and dosage forms may not be
Maximum dose: Valsartan 320 mg/hydrochlorothiazide 25 mg per day. Add-on/replacement therapy: Valsartan 80 to 320 mg/hydrochlorothiazide 12.5 to 25 mg once daily; titrate as needed based on patient response after 3 to 4 weeks of therapy. Maximum dose: Valsartan 320 mg/hydrochlorothiazide 25 mg per day. Dosing: Geriatric. Refer to adult dosing.
Amlodipine/Valsartan/HCT Novartis a amlodipine 10 mg valsartan 320 mg hydrochlorothiazide 25 mg tablet, 28.
mg of hydrochlorothiazide or 320 of valsartan and 25 mg of hydrochlorothiazide. the criteria for biowaiver for additional strengths are fulfilled
Maximum dose: Valsartan 320 mg/hydrochlorothiazide 25 mg per day. While in case of add-on/replacement therapy: Valsartan 80 to 320 mg/hydrochlorothiazide 12.5
of valsartan/hydrochlorothiazide 320/25 mg (15.4/10.4 mmHg) and valsartan/hydrochlorothiazide. 320/12.5 mg (13.6/9.7 mmHg) compared to valsartan 320 mg (6.1
Comments